Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 498

1.

A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.

van den Broek WW, Birkenhäger TK, Mulder PG, Bruijn JA, Moleman P.

Psychopharmacology (Berl). 2004 Oct;175(4):481-6.

PMID:
15243735
[PubMed - indexed for MEDLINE]
2.

Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.

Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.

Am J Psychiatry. 2004 Nov;161(11):2060-5.

PMID:
15514407
[PubMed - indexed for MEDLINE]
3.

Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.

Volkers AC, Tulen JH, van den Broek WW, Bruyn JA, Passchier J, Pepplinkhuizen L.

Pharmacopsychiatry. 2004 Jan;37(1):18-25.

PMID:
14750044
[PubMed - indexed for MEDLINE]
4.

Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.

Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP.

J Clin Psychopharmacol. 1996 Apr;16(2):113-20.

PMID:
8690826
[PubMed - indexed for MEDLINE]
5.

Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.

Fabre L, Birkhimer LJ, Zaborny BA, Wong LF, Kapik BM.

Int Clin Psychopharmacol. 1996 Jun;11(2):119-27.

PMID:
8803649
[PubMed - indexed for MEDLINE]
6.

Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.

van den Broek WW, Birkenhäger TK, Mulder PG, Bruijn JA, Moleman P.

J Clin Psychiatry. 2006 Feb;67(2):263-8.

PMID:
16566622
[PubMed - indexed for MEDLINE]
7.
8.

A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.

Otsubo T, Akimoto Y, Yamada H, Koda R, Aoyama H, Tanaka K, Mimura M, Nakagome K, Kamijima K.

Pharmacopsychiatry. 2005 Jan;38(1):30-5.

PMID:
15706464
[PubMed - indexed for MEDLINE]
9.

A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients.

Bruijn JA, Moleman P, Mulder PG, van den Broek WW, van Hulst AM, van der Mast RC, van de Wetering BJ.

Psychopharmacology (Berl). 1996 Oct;127(3):231-7.

PMID:
8912401
[PubMed - indexed for MEDLINE]
10.

Treatment of mood-congruent psychotic depression with imipramine.

Bruijn JA, Moleman P, Mulder PG, van den Broek WW.

J Affect Disord. 2001 Oct;66(2-3):165-74.

PMID:
11578669
[PubMed - indexed for MEDLINE]
11.

Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.

Nair NP, Bakish D, Saxena B, Amin M, Schwartz G, West TE.

Anxiety. 1996;2(4):192-8.

PMID:
9160622
[PubMed - indexed for MEDLINE]
12.

Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.

Rossini D, Serretti A, Franchini L, Mandelli L, Smeraldi E, De Ronchi D, Zanardi R.

J Clin Psychopharmacol. 2005 Oct;25(5):471-5.

PMID:
16160624
[PubMed - indexed for MEDLINE]
13.

Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study.

Asakura S, Tajima O, Koyama T.

Int J Neuropsychopharmacol. 2007 Apr;10(2):263-74. Epub 2006 Mar 30.

PMID:
16573847
[PubMed - indexed for MEDLINE]
14.

A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients.

Vermeiden M, Mulder PG, van den Broek WW, Bruijn JA, Birkenhäger TK.

J Psychiatr Res. 2013 Oct;47(10):1337-42. doi: 10.1016/j.jpsychires.2013.05.029. Epub 2013 Jun 22.

PMID:
23800419
[PubMed - indexed for MEDLINE]
15.

Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.

Kasper S, Möller HJ, Montgomery SA, Zondag E.

Int Clin Psychopharmacol. 1995 Jan;9 Suppl 4:3-12.

PMID:
7622821
[PubMed - indexed for MEDLINE]
16.

CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine.

Koetsier GC, Volkers AC, Tulen JH, Passchier J, van den Broek WW, Bruijn JA.

J Psychiatr Res. 2002 Nov-Dec;36(6):391-7.

PMID:
12393308
[PubMed - indexed for MEDLINE]
17.

Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants.

Heijnen WT, van den Broek WW, Mulder PG, Birkenhäger TK.

J Psychopharmacol. 2010 Apr;24(4):559-63. doi: 10.1177/0269881108099213. Epub 2008 Nov 21.

PMID:
19028834
[PubMed - indexed for MEDLINE]
18.

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.

Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.

Arch Gen Psychiatry. 2004 Dec;61(12):1235-44.

PMID:
15583115
[PubMed - indexed for MEDLINE]
19.

Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine.

Chiu HJ, Hong CJ, Chan CH.

Zhonghua Yi Xue Za Zhi (Taipei). 1996 Jun;57(6):418-23.

PMID:
8803304
[PubMed - indexed for MEDLINE]
20.

Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression.

Vezmar S, Miljkovic B, Vucicevic K, Timotijevic I, Prostran M, Todorovic Z, Pokrajac M.

J Pharmacol Sci. 2009 May;110(1):98-104.

PMID:
19444001
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk